Segment Information (Tables)

9 Months Ended

Jun. 30, 2012

Financial Information for Business Segments

Financial information for the Company’s business segments is as follows (in thousands):

	Brooks Product Solutions		Brooks Global Services		Brooks Life Science Systems			Contract Manufacturing		Total
Three months ended June 30, 2012
Revenues
Product	$	107,725	$	2,981	$	8,466		$	—	$	119,172
Services		—		18,543		2,722			—		21,265
	$	107,725	$	21,524	$	11,188		$	—	$	140,437
Gross profit	$	36,195	$	5,868	$	4,177		$	—	$	46,240
Segment operating income (loss)	$	10,733	$	1,984	$	(2,061	)	$	—	$	10,656
Three months ended June 30, 2011
Revenues
Product	$	119,092	$	3,573	$	1,677		$	42,316	$	166,658
Services		—		18,996		482			—		19,478
	$	119,092	$	22,569	$	2,159		$	42,316	$	186,136
Gross profit	$	44,433	$	7,903	$	650		$	3,984	$	56,970
Segment operating income (loss)	$	18,737	$	3,522	$	(1,196	)	$	2,006	$	23,069
Nine months ended June 30, 2012
Revenues
Product	$	296,475	$	8,373	$	29,043		$	—	$	333,891
Services		—		56,480		9,631			—		66,111
	$	296,475	$	64,853	$	38,674		$	—	$	400,002
Gross profit	$	100,481	$	19,595	$	14,803		$	—	$	134,879
Segment operating income (loss)	$	19,415	$	7,128	$	(2,799	)	$	—	$	23,744
Nine months ended June 30, 2011
Revenues
Product	$	352,757	$	11,020	$	1,677		$	137,329	$	502,783
Services		—		53,889		482			—		54,371
	$	352,757	$	64,909	$	2,159		$	137,329	$	557,154
Gross profit	$	135,013	$	23,090	$	650		$	17,210	$	175,963
Segment operating income (loss)	$	56,884	$	9,094	$	(1,196	)	$	10,650	$	75,432
Assets
June 30, 2012	$	237,455	$	56,036	$	106,205		$	—	$	399,696
September 30, 2011	$	235,322	$	52,354	$	101,331		$	—	$	389,007

Reconciliation of Reportable Segment Operating Income to Corresponding Consolidated Amounts

A reconciliation of the Company’s reportable segment operating income to the corresponding consolidated amounts for the three and nine month periods ended June 30, 2012 and 2011 is as follows (in thousands):

	Three months ended June 30,				Nine months ended June 30,
	2012		2011		2012			2011
Segment operating income	$	10,656	$	23,069	$	23,744		$	75,432
Other unallocated corporate expenses		316		305		(2,100	)		839
Amortization of acquired intangible assets		1,135		495		3,490			1,394
Restructuring charges		880		97		1,125			557
In-process research and development		—		—		3,026			—
Total operating income	$	8,325	$	22,172	$	18,203		$	72,642

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

A reconciliation of the Company’s reportable segment assets to the corresponding consolidated amounts as of June 30, 2012 and September 30, 2011 is as follows (in thousands):

	June 30, 2012		September 30, 2011
Segment assets	$	399,696	$	389,007
Investments in cash equivalents, marketable securities, joint ventures, and other unallocated corporate net assets		245,627		247,951
Total assets	$	645,323	$	636,958